Srour, M. et al. Gene expression comparison between primary triple-negative breast cancer and matched axillary lymph node metastasis. Poster session presented at: American Society of Clinical Oncology (ASCO) Annual Meeting; 2019 Jun 2, Chicago, IL.
Download pdf 1.2MB
View External Link
Szabo, P. M., et al. Association of an Inflammatory Gene Signature with CD8 Expression by Immunohistochemistry (IHC) in Multiple Tumor Types. Poster session presented at: American Society of Clinical Oncology (ASCO) Annual Meeting; June 1, 2019, Chicago, IL.
Download pdf 606KB
View External Link
Sinn, B.V., et al. Pre-therapeutic PD-L1 expression and dynamics of Ki-67 and gene expression during neoadjuvant immune-checkpoint blockade and chemotherapy to predict response within the GeparNuevo trial. Abstract PD5-05 presented at: American Association for Cancer Research Breast Symposium; December 4-8, 2019. San Antonio, Texas.
Takahashi, Y., et al. PFKFB2 as a Potential Survival Marker in Sinonasal Undifferentiated Carcinoma. J Neuorol Surg B 2019; 80(S01): S1-S244.
Kanji, Z. S., et al. Target Capture RNA Sequencing as a Method of Predicting Response to Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Cancer a Multi-institutional Study. Journal of the International Hepato-Pancreato-Biliary Association. 2019; 21(S1):S14-S15.
Battaglin, F., et al. Genetic variants in the lipopolysaccharide (LPS) receptor complex and TLR4 expression levels to predict the efficacy of cetuximab (cet) in patients (pts) with metastatic colorectal cancer (mCRC): Data from the FIRE-3 phase III trial. American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium; January 19, 2019, San Francisco, CA.
Sunakawa, Y. et al. A biomarker study to validate predictors for clinical outcome of cetuximab based chemotherapy in first-line metastatic colorectal cancer (mCRC)patients. Abstract presented at: 2018 Congress European Society for Medical Oncology (ESMO); 2018 Oct 21; Munich, Germany. Annals of Oncology (2018) 29 (suppl_8): viii150-viii204. 10.1093/annonc/mdy281.
Loibl, S., et al. Randomized phase II neoadjuvant study (GepartNuevo) to investigate the addition of durvalumab to a taxane-anthracycline containing chemotherapy in triple negative breast cancer (TNBC). Clinical Science Symposium Presented at: American Society of Clinical Oncology (ASCO); 2018 June 2, Chicago, IL.
Koshkin, V. S., et al, Correlation between gene expression and prognostic biomarkers in small cell bladder cancer (SCBC). Abstract #4546 Presented at: American Society of Clinical Oncology; 2018 June 2; Chicago, IL.
Gulley, J. L., et al, Effect of rilimogene galvacirepvec/rilimogene glafolivec on intra/peritumoral immune infiltrate in patients with localized prostate cancer undergoing radical prostatectomy. Abstract #5083 Presented at: American Society of Clinical Oncology (ASCO); 2018 June 2; Chicago, IL.
Sarihan, E., et al. A biologic basis for locoregional failure in patients with oral cavity cancers. Poster #3681 Presented at: American Association for Cancer Research (AACR); 2018 Apr 14-18; Chicago, IL
Wistuba I., et al, Tumor cells of the early metastatic process show upregulation of cytokine genes involved in migration of inflammatory cells. Poster session #1105 presented at: American Association of Cancer Research (AACR) Annual Meeting; 2018 Apr 14 - 18, 2018; Chicago, IL
Page last updated May 22, 2023